A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF
NCT01566578
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Plaque Psoriasis
Interventions
DRUG:
Human recombinant epidermal growth factor
OTHER:
Placebo cream
Sponsor
Ennar Pharmaceuticals AF
Collaborators
[object Object]